Neanderthal DNA Leaves a Measurable Mark on the Modern Human Brain

A small stretch of inherited Neanderthal DNA appears to have done something unusually large to the modern human brain. In a new analysis published in Proceedings of the National Academy of Sciences USA, evolutionary geneticists traced a four-nucleotide deletion on chromosome 14 to Neanderthal genomes and linked it to a reduction in the volume of the cuneus, a visual-processing region within the occipital lobe. Each copy of the variant corresponded to 0.85 cubic centimetres less cuneus volume, an effect described as larger than that of any other known variant on that structure.

The signal does not stop at anatomy. People carrying the variant also have a reduced risk of schizophrenia, a finding that places the variant squarely at the intersection of neurodevelopment, brain structure, and psychiatric vulnerability.

A single inherited deletion is doing work that most common variants do not come close to matching.

A Fossil Legacy Embedded in Contemporary Genomes

The analysis compared ancient DNA with modern resources, including data from the 1000 Genomes Project and UK Biobank, to determine where this variant came from and how it behaves in living humans. The variant was found in all five detailed Neanderthal genomes available to scientists, but it was absent from Denisovan genomes. In modern humans, it appears only in people with non-African ancestry, a pattern that fits inheritance from Neanderthal admixture rather than descent from a much older shared ancestor.

The DNA segment surrounding the deletion spans 59.7 kilobases, a length too large to have persisted unchanged for hundreds of thousands of years if it had been inherited from a species ancestral to both humans and Neanderthals. That genomic context makes the evolutionary origin hard to ignore. The simplest interpretation is also the most biologically direct: this is a Neanderthal-derived fragment that modern humans still carry, and it continues to shape the brain in ways that can be measured.

The deletion itself removes four nucleotides on chromosome 14. The variant was originally identified in 2019, but the new work ties it to a much more specific neuroanatomical effect than was previously appreciated. Its influence runs counter to the broad intuition that Neanderthal ancestry should map neatly onto one direction of brain change. Neanderthals generally had larger occipital lobes than modern humans, yet this particular inherited segment is associated with a smaller cuneus in the human brain. Evolution rarely moves in one straight line.

Visual Cortex Anatomy and the Cost of Small Changes

The occipital lobe sits at the back of the brain and is central to visual processing. The cuneus, one component of that region, helps organize visual input and contributes to how the brain handles spatial and perceptual information. Even modest volumetric shifts in a structure involved in sensory integration can matter when they occur consistently across populations.

Here, the effect size is striking. A reduction of 0.85 cubic centimetres per copy is not a subtle statistical footnote; it is a visible anatomical shift tied to a defined inherited sequence. Davide Marnetto, a computational biologist at the University of Turin, described the variant as exceptionally important and emphasized the strength of its effect. That assessment reflects the unusual magnitude of the association rather than any speculative leap beyond the data.

The finding also raises a practical question for neuroscience: how many other common structural differences in the brain are being driven by ancient DNA fragments whose biological consequences have not yet been mapped? The answer is likely more than is currently appreciated, especially when the variant is strong enough to leave a clear fingerprint on a specific cortical region.

Schizophrenia Risk and the Evolution of Brain Trade-offs

The schizophrenia association makes the variant more than an evolutionary curiosity. It suggests that a sequence inherited from Neanderthals may have carried a trade-off: one effect on brain anatomy, another on psychiatric vulnerability. The article does not quantify the size of the schizophrenia risk reduction, so the safe reading is narrower but still important. Carrying the variant is associated with reduced risk, and the same sequence also alters occipital lobe anatomy. Those two observations together imply that the deletion affects a neurodevelopmental pathway with consequences extending beyond gross structure.

That kind of dual effect is biologically plausible. Genes that influence cortical development often affect both regional brain size and vulnerability to neuropsychiatric conditions, because the same developmental program helps shape structure, connectivity, and later circuit function. A variant that subtly changes occipital lobe development may therefore influence visual cortex maturation, downstream network organization, and susceptibility to disorders in which neurodevelopmental risk is a central feature.

The study does not claim that the deletion explains schizophrenia. It does show that one inherited Neanderthal fragment tracks with both a brain morphology trait and a psychiatric outcome, which is enough to make the variant clinically interesting even without overstating causality.

What This Means for Human Evolution Research

The work sharpens a broader point about ancient introgression: Neanderthal DNA is not just a relic sitting quietly in the background of modern genomes. Some fragments continue to exert measurable effects on present-day biology, including traits as complex as brain anatomy. In this case, the effect is specific enough to implicate a visual-processing subregion, large enough to be notable against the backdrop of known human variation, and linked to a psychiatric phenotype with clear clinical relevance.

Future work will need to determine the molecular mechanism behind the deletion’s effect on the cuneus and why it tracks with lower schizophrenia risk. The current article does not provide those answers, and it does not identify a therapeutic target. What it does provide is a rare and unusually clean example of ancient DNA influencing a modern human brain trait in a way that can be measured across large genomic datasets.

The genomic fragment is ancient. The phenotype is current. The biology sits between them.


Reporting by Dr. A. Manasa, MBBS for Medicine World Foundation, with additional data provided by Nature Reviews Neurology.
PRIMARY CLINICAL EVIDENCE & REGISTRY DATA